Business Description
Acrobiosystems Co Ltd
ISIN : CNE100004S13
Share Class Description:
SZSE:301080: Class ATotal Employee Number:
926Compare
Compare
Traded in other countries / regions
301080.China IPO Date
2021-10-18Description
Acrobiosystems Co Ltd is a global brand focusing on protein technology, products and services in the development of biological drugs. It is committed to providing target antigens and other key reagents and related services required in the development of targeted therapeutic drugs.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 15.93 | |||||
Equity-to-Asset | 0.91 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | 0.47 | |||||
Interest Coverage | 216.65 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 24.19 | |||||
Beneish M-Score | -1.46 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 21 | |||||
3-Year EBITDA Growth Rate | -1.5 | |||||
3-Year EPS without NRI Growth Rate | 8.7 | |||||
3-Year Book Growth Rate | 1.4 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 92.31 | |||||
9-Day RSI | 85.81 | |||||
14-Day RSI | 81.27 | |||||
3-1 Month Momentum % | 13.78 | |||||
6-1 Month Momentum % | -0.2 | |||||
12-1 Month Momentum % | -6.57 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 13.3 | |||||
Quick Ratio | 11.22 | |||||
Cash Ratio | 10.06 | |||||
Days Inventory | 1154.27 | |||||
Days Sales Outstanding | 48.83 | |||||
Days Payable | 344.49 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.73 | |||||
Dividend Payout Ratio | 0.2 | |||||
3-Year Dividend Growth Rate | -11.2 | |||||
Forward Dividend Yield % | 0.73 | |||||
5-Year Yield-on-Cost % | 0.77 | |||||
3-Year Average Share Buyback Ratio | 0.2 | |||||
Shareholder Yield % | 1.22 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 91.11 | |||||
Operating Margin % | 24.03 | |||||
Net Margin % | 19.3 | |||||
EBITDA Margin % | 19.87 | |||||
FCF Margin % | 15.87 | |||||
OCF Margin % | 40.83 | |||||
ROE % | 6.47 | |||||
ROA % | 5.85 | |||||
ROIC % | 18.07 | |||||
3-Year ROIIC % | 4.18 | |||||
ROC (Joel Greenblatt) % | 22.94 | |||||
ROCE % | 6.43 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 79.19 | |||||
Forward PE Ratio | 57.27 | |||||
PE Ratio without NRI | 56.46 | |||||
Price-to-Owner-Earnings | 934.09 | |||||
PEG Ratio | 16.61 | |||||
PS Ratio | 15.31 | |||||
PB Ratio | 5.09 | |||||
Price-to-Tangible-Book | 5.15 | |||||
Price-to-Free-Cash-Flow | 96.82 | |||||
Price-to-Operating-Cash-Flow | 37.7 | |||||
EV-to-EBIT | 66.82 | |||||
EV-to-EBITDA | 66.82 | |||||
EV-to-Revenue | 13.28 | |||||
EV-to-FCF | 83.65 | |||||
Price-to-GF-Value | 1.37 | |||||
Price-to-Projected-FCF | 5.75 | |||||
Price-to-Graham-Number | 3.59 | |||||
| Price-to-Net-Current-Asset-Value | 9.46 | |||||
| Price-to-Net-Cash | 13.34 | |||||
Earnings Yield (Greenblatt) % | 1.5 | |||||
FCF Yield % | 1.02 | |||||
Forward Rate of Return (Yacktman) % | -9.65 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Acrobiosystems Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 887.213 | ||
| EPS (TTM) (Â¥) | 1.038 | ||
| Beta | 1.6222 | ||
| 3-Year Sharpe Ratio | 0.11 | ||
| 3-Year Sortino Ratio | 0.16 | ||
| Volatility % | 33.04 | ||
| 14-Day RSI | 81.27 | ||
| 14-Day ATR (Â¥) | 5.450002 | ||
| 20-Day SMA (Â¥) | 56.444 | ||
| 12-1 Month Momentum % | -6.57 | ||
| 52-Week Range (Â¥) | 35.87 - 88.88 | ||
| Shares Outstanding (Mil) | 167.68 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Acrobiosystems Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Acrobiosystems Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| CNY 0.600000 Cash Dividend | 2026-06-11 | 37.55 (+2.04%) | ||
| CNY 0.285714 Cash Dividend | 2025-07-11 | 48.86 (-2.98%) | ||
| 1.4:1 Stock Split | 2025-07-11 | 48.86 (-2.98%) | ||
| CNY 0.214286 Cash Dividend | 2025-01-24 | 35.59 (-2.26%) | ||
| 1.5:1 Stock Split | 2023-06-07 | 43.39 (-2.64%) |
Show
Entries
Acrobiosystems Co Ltd Frequently Asked Questions
What is Acrobiosystems Co Ltd(SZSE:301080)'s stock price today?
The current price of SZSE:301080 is ¥82.20. The 52 week high of SZSE:301080 is ¥88.88 and 52 week low is ¥35.87.
When is next earnings date of Acrobiosystems Co Ltd(SZSE:301080)?
The next earnings date of Acrobiosystems Co Ltd(SZSE:301080) is .
Does Acrobiosystems Co Ltd(SZSE:301080) pay dividends? If so, how much?
The Dividend Yield %  of Acrobiosystems Co Ltd(SZSE:301080) is 0.73% (As of Today), Highest Dividend Payout Ratio of Acrobiosystems Co Ltd(SZSE:301080) was 1.28. The lowest was 0.2. And the median was 0.95. The  Forward Dividend Yield % of Acrobiosystems Co Ltd(SZSE:301080) is 0.73%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Articles on Acrobiosystems Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers